TRICURE device study for leaky heart valve
Part of Heart & circulation clinical trials.
This study tests a new device to help people with severe tricuspid regurgitation (leaky heart valve) who are at higher risk from surgery. It aims to see if the device can reduce the leak and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have severe (grade 3) tricuspid regurgitation (a leaky heart valve).
- Your heart doctors have decided you have a higher risk from heart surgery.
- You are not in need of an emergency heart procedure.
- You are currently stable (not in a life-threatening heart situation).
- Your heart anatomy is suitable for the trial device (determined by your doctor).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called TricValve, which is placed through a catheter (a thin tube) to fix a leaky tricuspid valve on the right side of the heart. It aims to reduce blood flowing backward and improve heart failure symptoms for people who can't have open-heart surgery and haven't been helped by other catheter treatments.
This study tests a new device to fix a leaky tricuspid valve without open-heart surgery. It is for people with severe leakage who are considered too high-risk for traditional surgery.
This trial tests how well a new catheter-based valve system works for people with severe (or worse) tricuspid valve leaking who still have symptoms despite medicines. It aims to improve outcomes by treating the leaking valve without open-heart surgery, if your heart structure and overall health fit the study.
This trial tests a new device called the Laplace system, which replaces the tricuspid valve in your heart without open-heart surgery. It is designed for people with severe tricuspid regurgitation (a leaky heart valve) who still have symptoms despite taking medications.
This trial tests a new device called the Medtronic Intrepid TTVR system to replace the tricuspid valve in people with severe tricuspid regurgitation (leaky valve). It aims to see if the device can safely and effectively fix the leak and improve symptoms.
This study tests a new, catheter-based procedure to treat moderate-to-severe leaking of the tricuspid valve (a heart valve on the right side). It’s for people who are high surgical risk and might benefit from replacing the valve without open-heart surgery.
Hear when a new Tricuspid Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.